Labeled for this condition
Medicines for rheumatoid arthritis
46 medicines have an FDA label indicated for rheumatoid arthritis; 28 are listed from generic labelers and 2 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for rheumatoid arthritis?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Ibuprofen | Advil, Motrin, Caldolor | 245 labelers | $0.0573 per tablet 800 mg tablet | Yes | No current entry | 40 |
| Naproxen | Aleve, Naprelan, Bayer | 139 labelers | $0.0565 per tablet 500 mg tablet | Yes | No current entry | 8 |
| Diclofenac | Voltaren, Zipsor, Cambia | 149 labelers | $0.0619 per tablet 75 mg tablet | Yes | A presentation being discontinued | 6 |
| Dexamethasone | Ozurdex, Maxidex, Hemady | 60 labelers | $0.193 per tablet 4 mg tablet | No | In shortage | 8 |
| Celecoxib | Celebrex, Vyscoxa | 63 labelers | $0.0762 per capsule 200 mg capsule | Yes | No current entry | 2 |
| Meloxicam | Qamzova, Xifyrm, Zybic | 43 labelers | $0.0166 per tablet 7.5 mg tablet | Yes | No current entry | 3 |
| Etodolac | none listed | 30 labelers | $0.262 per tablet 400 mg tablet | Yes | No current entry | 0 |
| Indomethacin | Indocin | 31 labelers | $0.210 per capsule 75 mg capsule | Yes | No current entry | 9 |
| Methotrexate | Rasuvo, Otrexup, Jylamvo | 29 labelers | $0.158 per tablet 2.5 mg tablet | Yes | In shortage | 8 |
| Adalimumab | Amjevita, Humira, Hyrimoz | none listed | $1,587.82 per mL 40 mg/0.4 mL | Yes | No current entry | 1 |
| Nabumetone | Relafen | 28 labelers | $0.128 per tablet 500 mg tablet | Yes | No current entry | 1 |
| Hydroxychloroquine | Plaquenil, Sovuna | 28 labelers | $0.149 per tablet 200 mg tablet | No | A presentation being discontinued | 2 |
| Tofacitinib | Xeljanz | 24 labelers | $0.573 per tablet 5 mg tablet | Yes | No current entry | 0 |
| Cyclosporine | Sandimmune, Neoral, Restasis | 14 labelers | $1.04 per unit 0.05% eye emulsion | Yes | No current entry | 7 |
| Leflunomide | Arava | 16 labelers | $0.324 per tablet 10 mg tablet | Yes | A presentation being discontinued | 2 |
| Azathioprine | Imuran, Azasan | 17 labelers | $0.124 per tablet 50 mg tablet | Yes | No current entry | 1 |
| Diclofenac and misoprostol | Arthrotec | 10 labelers | $0.665 per tablet 50-0.2 mg tablet | Yes | No current entry | 7 |
| Piroxicam | none listed | 10 labelers | $0.215 per capsule 20 mg capsule | Yes | No current entry | 0 |
| Tocilizumab | Tyenne, Tofidence, Actemra | none listed | $821.00 per mL 162 mg/0.9 mL autoinjct | Yes | No current entry | 1 |
| Famotidine and ibuprofen | none listed | 16 labelers | $0.714 per unit 800-26.6 mg | Yes | No current entry | 1 |
| Adalimumab-adbm | Cyltezo | none listed | $639.19 per pen 40 mg/0.4 mL | Yes | No current entry | 0 |
| Sulfasalazine | Azulfidine | 5 labelers | $0.199 per tablet 500 mg tablet | No | No current entry | 0 |
| Sulindac | none listed | 7 labelers | $0.189 per tablet 150 mg tablet | Yes | No current entry | 1 |
| Adalimumab-ryvk | Simlandi | none listed | $499.12 per unit 40 mg/0.4 mL autoinjector | Yes | A presentation being discontinued | 0 |
| Penicillamine | Depen, Cuprimine, Aagylur | 9 labelers | n/a | Yes | No current entry | 1 |
| Fenoprofen | none listed | 6 labelers | n/a | Yes | No current entry | 0 |
| Oxaprozin | Coxanto | 7 labelers | $0.475 per tablet 600 mg tablet | Yes | No current entry | 0 |
| Flurbiprofen | Lurbiro | 7 labelers | $9.83 per mL 0.03% eye drop | No | No current entry | 0 |
| Rituximab | Riabni, Ruxience, Rituxan | none listed | n/a | Yes | No current entry | 1 |
| Diflunisal | Dolobid | 6 labelers | $1.06 per tablet 500 mg tablet | Yes | No current entry | 0 |
| Ketoprofen | Orudis | 5 labelers | $6.46 per capsule 200 mg capsule | Yes | No current entry | 0 |
| Tolmetin | none listed | 5 labelers | n/a | Yes | No current entry | 0 |
| Adalimumab-aaty | Yuflyma | none listed | $495.75 per unit 40 mg/0.4 mL autoinjector | Yes | No current entry | 0 |
| Adalimumab-afzb | Abrilada | none listed | n/a | Yes | A presentation being discontinued | 0 |
| Adalimumab-fkjp | Hulio | none listed | n/a | Yes | No current entry | 0 |
| Etanercept | Enbrel | none listed | $2,084.14 per mL 25 mg/0.5 mL syringe | Yes | No current entry | 0 |
| Infliximab | Remicade, Inflectra, Renflexis | none listed | n/a | Yes | No current entry | 2 |
| Abatacept | Orencia | none listed | $1,469.23 per mL 125 mg/mL syringe | No | No current entry | 0 |
| Baricitinib | Olumiant | none listed | $92.54 per tablet 2 mg tablet | Yes | No current entry | 0 |
| Sarilumab | Kevzara | none listed | $2,075.30 per mL 200 mg/1.14 mL pen injection | Yes | No current entry | 0 |
| Upadacitinib | Rinvoq | none listed | $229.31 per tablet 15 mg tablet | Yes | No current entry | 0 |
| Certolizumab | Cimzia | none listed | $6,094.02 per syringe 2x200 mg/mL syringe kit | Yes | No current entry | 1 |
| Golimumab | Simponi | none listed | $12,890.32 per mL 50 mg/0.5 mL pen injec | Yes | No current entry | 0 |
| Adalimumab-aacf | Idacio | none listed | n/a | Yes | No current entry | 0 |
| Auranofin | Ridaura | none listed | $24.85 per capsule 3 mg capsule | Yes | No current entry | 0 |
| Meclofenamate | none listed | 1 labeler | n/a | Yes | No current entry | 0 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price